Clin2
NCT07158229Likely a fitRecruiting

Long-term effects of NMDAR encephalitis

NMDAR Autoimmune Encephalitis

Part of Brain & nervous system clinical trials.

This study follows adults with NMDAR encephalitis over time to understand its long-term effects. It uses online questionnaires, so you need internet access at home.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You have been diagnosed with NMDAR encephalitis (a type of brain inflammation linked to antibodies).
  • You are 18 years old or older.
  • You are registered with a social security system (health insurance in France).
  • You have access to the internet and a computer to participate in follow-up.
  • You do not have any other brain or nerve condition that started before the encephalitis.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07133113Recruiting
Effects of treatments in autoimmune encephalitis

This study follows patients with autoimmune encephalitis (brain inflammation caused by the immune system) to see how treatments affect them in the medium term. It may help doctors learn which treatments work best for people with this condition.

Bron
NCT05772611Recruiting
Study of immune responses in brain autoimmune and nerve syndromes

This study looks at how the immune system works in certain neurological conditions, including autoimmune encephalitis and related nerve disorders. Researchers may use blood and/or spinal fluid samples, especially when antibodies are present or can’t be found, to better understand what’s driving the illness.

Lyon
NCT07477015Recruiting
Study to find new antibodies in autoimmune encephalitis

This research study looks for new markers in the blood of people with autoimmune encephalitis (a condition where the immune system attacks the brain). It aims to better understand what causes the disease and find new ways to diagnose it.

Rome, RM
NCT07093333Recruiting· Phase 2
Testing a new antibody treatment for anti-NMDAR brain disease

This study tests a new medicine (ART5803) in people whose immune system attacks a brain receptor called NMDAR, causing encephalitis (brain swelling) or psychiatric symptoms. It aims to see if the medicine can reduce symptoms like confusion, memory problems, or psychosis.

Seoul
NCT06760091Not yet recruiting
Autoimmune encephalitis study

This study is for people with autoimmune encephalitis, a condition where the immune system attacks the brain. It aims to collect information about this disease to learn more about it and how to treat it.

Beijing
NCT07333196Not yet recruiting
Long-term study of brain and nerve diseases

This observational study follows people with various immune-related neurological conditions, such as multiple sclerosis, neuromyelitis optica, and autoimmune encephalitis. It aims to better understand these diseases and their progression over time.

Wuhan, Hubei

Hear when a new NMDAR Autoimmune Encephalitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.